Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.765
+0.065 (3.81%)
At close: Jan 21, 2025, 4:00 PM
1.680
-0.085 (-4.81%)
After-hours: Jan 21, 2025, 4:18 PM EST
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $6.12 million as of January 21, 2025. Its market cap has decreased by -57.50% in one year.
Market Cap
6.12M
Enterprise Value
5.10M
1-Year Change
-57.50%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $6.12M, a decrease of -91.83%. That is a compound annual growth rate of -23.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 17, 2025 | 5.90M | 1.72% |
Dec 31, 2024 | 5.80M | -60.00% |
Dec 29, 2023 | 14.50M | -65.31% |
Dec 30, 2022 | 41.80M | -45.07% |
Dec 31, 2021 | 76.10M | 70.25% |
Dec 31, 2020 | 44.70M | 45.13% |
Dec 31, 2019 | 30.80M | 528.57% |
Dec 31, 2018 | 4.90M | -42.35% |
Dec 29, 2017 | 8.50M | -58.74% |
Dec 30, 2016 | 20.60M | -62.34% |
Dec 31, 2015 | 54.70M | -26.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 653.46B |
UnitedHealth Group | 469.12B |
Johnson & Johnson | 353.99B |
Novo Nordisk | 341.33B |
AbbVie | 303.17B |
Merck & Co. | 247.70B |
Thermo Fisher Scientific | 214.07B |
Intuitive Surgical | 211.09B |